RiboPro

Oss, Netherlands Founded: 2020 • Age: 6 yrs
Online supplier and developer of RNA based products

About RiboPro

RiboPro is a company based in Oss (Netherlands) founded in 2020.. RiboPro has raised $1.43 million across 3 funding rounds from investors including Rockstart, BOM and Vlasroot. RiboPro offers products and services including Custom mRNA, Off-the-shelf mRNA, LNP Formulation, and GMP Services. RiboPro operates in a competitive market with competitors including Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and Invivyd, among others.

  • Headquarter Oss, Netherlands
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.43 M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.08 M (USD), Debt – Convertible

    Jan 12, 2024

  • Investors
    Rockstart

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of RiboPro

RiboPro offers a comprehensive portfolio of products and services, including Custom mRNA, Off-the-shelf mRNA, LNP Formulation, and GMP Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides tailored mRNA production for research and therapy.

Offers pre-made mRNA for immediate biotechnology use.

Encapsulates mRNA into LNPs for efficient delivery.

Assists with GMP-compliant manufacturing processes.

People of RiboPro
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Tom Berendsen
Financial Controller
People
Yvette Zimmerman
Chief Operating Officer
People
Luke Tomà
Head Of Production
People
Tim Janssen
Chief Financial Officer

Unlock access to complete

Funding Insights of RiboPro

RiboPro has successfully raised a total of $1.43M across 3 strategic funding rounds. The most recent funding activity was a Debt – Convertible round of $2.08 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Debt – Convertible — $2.1M
  • First Round

    (22 Mar 2021)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Debt – Convertible - RiboPro Valuation Vlasroot , BOM
Jun, 2023 Amount Series A - RiboPro Valuation

investors

Mar, 2021 Amount Seed - RiboPro Valuation Vlasroot
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in RiboPro

RiboPro has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Rockstart, BOM and Vlasroot. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Investments are directed by BOM toward early and growth-stage firms.
Founded Year Domain Location
Early-stage startups are accelerated across energy, agrifood, and emerging technologies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by RiboPro

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - RiboPro

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ribopro Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of RiboPro

RiboPro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and Invivyd, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Stem cell therapies are developed for cardiovascular and neurological diseases.
domain founded_year HQ Location
Transformative therapies are developed and commercialized through specialized services.
domain founded_year HQ Location
Histopathology and genomics services are offered by the CRO.
domain founded_year HQ Location
Online insurance payments and premium financing are enabled for businesses.
domain founded_year HQ Location
Stem cell drug research and clinical trial services are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ribopro

Frequently Asked Questions about RiboPro

When was RiboPro founded?

RiboPro was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Where is RiboPro located?

RiboPro is headquartered in Oss, Netherlands. It is registered at Oss, Noord-brabant, Netherlands.

Is RiboPro a funded company?

RiboPro is a funded company, having raised a total of $1.43M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.43M, raised on Mar 22, 2021.

What does RiboPro do?

RiboPro is an online supplier and developer of messenger RNA, long non-coding RNA, and other RNA products. The platform offers tools to synthesize customized mRNA or IncRNA products. It offers off-the-shelf mRNa products such as eGFP mRNA and PLuc mRNA products for research application.

Who are the top competitors of RiboPro?

RiboPro's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.

What products or services does RiboPro offer?

RiboPro offers Custom mRNA, Off-the-shelf mRNA, LNP Formulation, and GMP Services.

Who are RiboPro's investors?

RiboPro has 3 investors. Key investors include Rockstart, BOM, and Vlasroot.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available